Fig. 1From: Similar outcomes following non-first-degree and first-degree related donor haploidentical hematopoietic cell transplantation for acute leukemia patients in complete remission: a study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationTransplant outcomes comparing the NFD or FD related HAPLOs. The upper part of the Figure shows the 180-day cumulative incidence of grade II-IV acute GVHD and 2-year cumulative incidences of cGVHD comparing the FD (red) and NFD (blue) cohorts. The middle part shows the 2-year cumulative incidence of relapse (RI) and non-relapse mortality (NRM). The lower part shows the 2-year leukemia-free survival (LFS) and overall survival (OS), respectivelyBack to article page